Advertisement
HALO vs INCY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HALO is a Buy and INCY is a Hold.
HALO's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for HALO turned positive on October 15, 2026. Looking at past instances where HALO's MACD turned positive, the stock continued to rise in 30 of 36 cases over the following month. The odds of a continued upward trend are 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on HALO as a result. In 60 of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
Following a +1.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where HALO advanced for three days, in 276 of 335 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 252 of 322 cases where HALO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HALO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
HALO broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 10 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is 11 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. HALO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: HALO's P/B Ratio (98.702) is slightly higher than the industry average of (2.988). P/E Ratio (35.163) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (7.968) is also within normal values, averaging (438.009).
INCY in upward trend: price may jump up because it broke its lower Bollinger Band on October 01, 2026
INCY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 26 of 40 cases where INCY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where INCY's RSI Oscillator exited the oversold zone, 20 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 59%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on INCY as a result. In 60 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for INCY just turned positive on October 20, 2026. Looking at past instances where INCY's MACD turned positive, the stock continued to rise in 20 of 35 cases over the following month. The odds of a continued upward trend are 57%.
Following a +3.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where INCY advanced for three days, in 208 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
INCY moved below its 50-day moving average on September 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for INCY crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INCY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
The Aroon Indicator for INCY entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. INCY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.624) is normal, around the industry mean (2.988). P/E Ratio (13.953) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (10.822) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (4.401) is also within normal values, averaging (438.009).
HALO | INCY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 40 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 92 Overvalued | |
PROFIT vs RISK RATING 1..100 | 10 | 38 | |
SMR RATING 1..100 | 11 | 33 | |
PRICE GROWTH RATING 1..100 | 35 | 45 | |
P/E GROWTH RATING 1..100 | 4 | 78 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
INCY's Valuation (92) in the Biotechnology industry is in the same range as HALO (99). This means that INCY’s stock grew similarly to HALO’s over the last 12 months.
HALO's Profit vs Risk Rating (10) in the Biotechnology industry is in the same range as INCY (38). This means that HALO’s stock grew similarly to INCY’s over the last 12 months.
HALO's SMR Rating (11) in the Biotechnology industry is in the same range as INCY (33). This means that HALO’s stock grew similarly to INCY’s over the last 12 months.
HALO's Price Growth Rating (35) in the Biotechnology industry is in the same range as INCY (45). This means that HALO’s stock grew similarly to INCY’s over the last 12 months.
HALO's P/E Growth Rating (4) in the Biotechnology industry is significantly better than the same rating for INCY (78). This means that HALO’s stock grew significantly faster than INCY’s over the last 12 months.
| HALO | INCY | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 59% | 2 days ago 59% |
| Stochastic ODDS (%) | 2 days ago 61% | 2 days ago 56% |
| Momentum ODDS (%) | 2 days ago 79% | 2 days ago 62% |
| MACD ODDS (%) | 2 days ago 83% | 2 days ago 57% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 65% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 57% |
| Advances ODDS (%) | 2 days ago 82% | 3 days ago 64% |
| Declines ODDS (%) | 22 days ago 61% | 10 days ago 55% |
| BollingerBands ODDS (%) | 2 days ago 57% | 2 days ago 65% |
| Aroon ODDS (%) | 2 days ago 78% | 2 days ago 57% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HALO’s FA Score shows that 3 FA rating(s) are green while INCY’s FA Score has 1 green FA rating(s).
- HALO’s FA Score: 3 green, 2 red.
- INCY’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HALO’s TA Score shows that 4 TA indicator(s) are bullish while INCY’s TA Score has 5 bullish TA indicator(s).
- HALO’s TA Score: 4 bullish, 4 bearish.
- INCY’s TA Score: 5 bullish, 5 bearish.
Price Growth
HALO (@Biotechnology) experienced а +6.86% price change this week, while INCY (@Biotechnology) price change was +1.68% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -18.30%, and the average quarterly price growth was -15.43%.
Reported Earning Dates
HALO is expected to report earnings on Nov 02, 2026.
INCY is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Biotechnology (-1.22% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
HALO and
Correlation & Price change
A.I.dvisor indicates that over the last year, HALO has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To HALO | 1D Price Change % | ||
|---|---|---|---|---|
| HALO | 100% | +0.37% | ||
| AXON - HALO | 47% Loosely correlated | +2.54% | ||
| INCY - HALO | 41% Loosely correlated | -2.72% | ||
| ONC - HALO | 39% Loosely correlated | +0.51% | ||
| GMAB - HALO | 37% Loosely correlated | +1.28% | ||
| VRTX - HALO | 37% Loosely correlated | +1.92% | ||
More | ||||